Cargando…
The Effects of Oral Magnesium Supplementation on Glycemic Response among Type 2 Diabetes Patients
Background: Magnesium (Mg) supplementation may help control glycemic response among type 2 diabetes (T2D) patients. Objective: This study means to determine whether Mg supplementation improves glycemic control indicators in patients with T2D. Methods: After one week of the dietary stabilization phas...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356710/ https://www.ncbi.nlm.nih.gov/pubmed/30587761 http://dx.doi.org/10.3390/nu11010044 |
_version_ | 1783391615569625088 |
---|---|
author | ELDerawi, Wafaa A. Naser, Ihab A. Taleb, Mahmmoud H. Abutair, Ayman S. |
author_facet | ELDerawi, Wafaa A. Naser, Ihab A. Taleb, Mahmmoud H. Abutair, Ayman S. |
author_sort | ELDerawi, Wafaa A. |
collection | PubMed |
description | Background: Magnesium (Mg) supplementation may help control glycemic response among type 2 diabetes (T2D) patients. Objective: This study means to determine whether Mg supplementation improves glycemic control indicators in patients with T2D. Methods: After one week of the dietary stabilization phase, 42 T2D patients were stratified according to sex, age, fasting blood sugar (FBS) and Mg levels and then randomly allocated into two groups. The intervention group was on 250 mg/day of elemental Mg for three months while the control group did not receive any type of supplements throughout the intervention period. Results: The daily administration of 250 mg of elemental Mg indicated a significant improvement in HbA1C (8.32 to 7.96%, p < 0.001), insulin levels (IL) (15.56 to 12.18 μIU/mL, p < 0.001), C-peptide (2.28 to 1.90 ng/mL, p = 0.001), HOMA.IR (6.16 to 4.44, p < 0.001) and HOMA.β% (59.99 to 52.37, p = 0.036) of the intervention group when compared with the control group after three months of intervention. Conclusion: The results of this study revealed that oral Mg supplementation reduces insulin resistance and improves the glycemic control indicators among T2D patients. Trial registration: current controlled trials PHRC/HC/32/15. Registered 5 October 2015. |
format | Online Article Text |
id | pubmed-6356710 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-63567102019-02-01 The Effects of Oral Magnesium Supplementation on Glycemic Response among Type 2 Diabetes Patients ELDerawi, Wafaa A. Naser, Ihab A. Taleb, Mahmmoud H. Abutair, Ayman S. Nutrients Article Background: Magnesium (Mg) supplementation may help control glycemic response among type 2 diabetes (T2D) patients. Objective: This study means to determine whether Mg supplementation improves glycemic control indicators in patients with T2D. Methods: After one week of the dietary stabilization phase, 42 T2D patients were stratified according to sex, age, fasting blood sugar (FBS) and Mg levels and then randomly allocated into two groups. The intervention group was on 250 mg/day of elemental Mg for three months while the control group did not receive any type of supplements throughout the intervention period. Results: The daily administration of 250 mg of elemental Mg indicated a significant improvement in HbA1C (8.32 to 7.96%, p < 0.001), insulin levels (IL) (15.56 to 12.18 μIU/mL, p < 0.001), C-peptide (2.28 to 1.90 ng/mL, p = 0.001), HOMA.IR (6.16 to 4.44, p < 0.001) and HOMA.β% (59.99 to 52.37, p = 0.036) of the intervention group when compared with the control group after three months of intervention. Conclusion: The results of this study revealed that oral Mg supplementation reduces insulin resistance and improves the glycemic control indicators among T2D patients. Trial registration: current controlled trials PHRC/HC/32/15. Registered 5 October 2015. MDPI 2018-12-26 /pmc/articles/PMC6356710/ /pubmed/30587761 http://dx.doi.org/10.3390/nu11010044 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article ELDerawi, Wafaa A. Naser, Ihab A. Taleb, Mahmmoud H. Abutair, Ayman S. The Effects of Oral Magnesium Supplementation on Glycemic Response among Type 2 Diabetes Patients |
title | The Effects of Oral Magnesium Supplementation on Glycemic Response among Type 2 Diabetes Patients |
title_full | The Effects of Oral Magnesium Supplementation on Glycemic Response among Type 2 Diabetes Patients |
title_fullStr | The Effects of Oral Magnesium Supplementation on Glycemic Response among Type 2 Diabetes Patients |
title_full_unstemmed | The Effects of Oral Magnesium Supplementation on Glycemic Response among Type 2 Diabetes Patients |
title_short | The Effects of Oral Magnesium Supplementation on Glycemic Response among Type 2 Diabetes Patients |
title_sort | effects of oral magnesium supplementation on glycemic response among type 2 diabetes patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356710/ https://www.ncbi.nlm.nih.gov/pubmed/30587761 http://dx.doi.org/10.3390/nu11010044 |
work_keys_str_mv | AT elderawiwafaaa theeffectsoforalmagnesiumsupplementationonglycemicresponseamongtype2diabetespatients AT naserihaba theeffectsoforalmagnesiumsupplementationonglycemicresponseamongtype2diabetespatients AT talebmahmmoudh theeffectsoforalmagnesiumsupplementationonglycemicresponseamongtype2diabetespatients AT abutairaymans theeffectsoforalmagnesiumsupplementationonglycemicresponseamongtype2diabetespatients AT elderawiwafaaa effectsoforalmagnesiumsupplementationonglycemicresponseamongtype2diabetespatients AT naserihaba effectsoforalmagnesiumsupplementationonglycemicresponseamongtype2diabetespatients AT talebmahmmoudh effectsoforalmagnesiumsupplementationonglycemicresponseamongtype2diabetespatients AT abutairaymans effectsoforalmagnesiumsupplementationonglycemicresponseamongtype2diabetespatients |